Skip to main content

Secondary Prevention of Cardiovascular Events - Use of Aspirin or Antiplatelet Therapy

CBE ID
0631
1.4 Project
National Voluntary Consensus Standards For Clinically Enriched Administrative Data
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
Previous Endorsement Cycle
Full Year 2009
Is Under Review
No
1.3 Measure Description

The percentage of adult patients, 21 years and older, with diagnosis of ischemic vascular disease (IVD) that are taking aspirin or an antiplatelet agent

    • 1.14 Numerator

      Patients that are taking aspirin or an antiplatelet agent in the past 6 months

    • 1.15 Denominator

      All patients, ages 21 and older, diagnosed with IVD as defined by coronary artery disease, peripheral vascular disease or cerebrovascular disease.

    • Exclusions

      Patients with contraindications to antithrombotic agents such as thrombocytopenia, coagulopathy, recent procedures, or current warfarin therapy

      General exclusions:
      • Evidence of metastatic disease or active treatment of malignancy (chemotherapy or radiation therapy) in the last 6 months;
      • Patients who have been in a skilled nursing facility in the last 3 months
      • Patient or provider feedback indicating allergy or intolerance to the drug in the past
      • Patient or provider feedback indicating that there is a contraindication to adding the drug

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed National Voluntary Consensus Standards For Clinically Enriched Administrative Data
      Initial Endorsement
      Last Updated
      Removal Date
    • Steward
      ActiveHealth Management
      Steward Organization POC Email
      [email protected]